Investors in Veradigm Inc (Symbol: MDRX) saw new options become available this week, for the January 2024 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDRX ...
As of December 16, 2023, the average one-year price target for Veradigm is 17.34. The forecasts range from a low of 13.13 to a high of $27.30. The average price target represents an increase of 61.30% ...
An update from Veradigm ( (MDRX)) is now available. On February 2, 2026, Veradigm’s board approved a further extension of the company’s Stockholder Rights Plan, pushing its expiration to December 31, ...
Veradigm ( (MDRX)) has issued an update. On December 31, 2025, healthcare technology firm Veradigm Inc. extended Interim Chief Financial Officer Leland Westerfield’s employment term through June 30, ...
SAN DIEGO, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired ...
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
NEW YORK, NY / ACCESSWIRE / December 6, 2023 / If you suffered a loss on your Veradigm Inc. (NASDAQ:MDRX) investment and want to learn about a potential recovery under the federal securities laws, ...
SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of Veradigm Inc. (NASDAQ: MDRX) common stock between February 26, 2021 and June 13, 2023, both dates inclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results